Cefuroximaxetil-GSK Pulver zur Herstellung einer Suspension zum Einnehmen
Country: Switzerland
Language: German
Source: Swissmedic (Swiss Agency for Therapeutic Products)
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
cefuroximum
Available from:
GlaxoSmithKline AG
ATC code:
J01DC02
INN (International Name):
cefuroximum
Pharmaceutical form:
Pulver zur Herstellung einer Suspension zum Einnehmen
Composition:
cefuroximum 125 mg ut cefuroximum axetili, arom.: vanillinum et alia, aspartamum, excipiens ad granulatum corresp. suspensio reconstituta 5 ml.
Class:
A
Therapeutic group:
Synthetika
Therapeutic area:
Infektionskrankheiten
Authorization status:
zugelassen
Authorization date:
2021-06-02
